HERPES ZOSTER NOVEL TREATMENT HOPE FROM TASMANIAN ABALONE GETS $1.2 MILLION BOOST

Sydney, Australia, 23 May 2011 – Leading Australian contract clinical research company Novotech, Marine Biotechnology Australia Pty Ltd [MBA] and the University of Sydney today announced a new Herpes research collaboration backed by the Academic Research Council [ARC]. The team aims to commercialize a novel treatment for Herpes simplex and Herpes zoster utilizing an extract [...]

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

NOVOTECH  INITIATES PHASE IB CANCER TRIALS IN AUSTRALIA AND NEW ZEALAND FOR CLIENT, ONCOMED PHARMACEUTICALS Sydney, Australia, 29 October 2010 – Novotech has announced initiation of three Phase Ib oncology trials at sites in Australia and New Zealand to test the safety, efficacy and pharmacokinetics of client OncoMed’s humanized monoclonal antibody product designed to target [...]

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Sydney, Australia – 27 October, 2010 News Facts Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with leading biotechnology and [...]

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC

Washington, DC, June 13, 2010 – Leading Australian contract clinical research company Novotech announced today that Novotech CEO Alek Safarian will be sharing the company’s Asia Region expertise and experience at DIA 2010 to be held in Washington, DC. Safarian will speak on “Global Study Experiences: Lessons from Observing Regional Variations” which is part of [...]

Novotech embarks on a new strategic partnership with Citeline, designed to accelerate patient recruitment and complete clinical studies more quickly.

Novotech embarks on a new strategic partnership with Citeline, designed to accelerate patient recruitment and complete clinical studies more quickly. NEW YORK – 15/4/10 – Novotech, a leading Australasian CRO, has engaged Citeline to support its clinical development programs and further improve the rate at which Sponsor clinical studies are planned and carried out. Citeline, [...]